Skip to navigation Skip to Content


Search Marshfield Clinic Health System
Join a world-class health system. Find jobs

Johnson & Johnson COVID-19 vaccinations paused

 April 13, 2021

Out of an overabundance of caution, Marshfield Clinic Health System will pause providing the Janssen (Johnson & Johnson) COVID-19 vaccine as recommended by the Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA).

The CDC and FDA recommended the U.S. pauses the use of the Janssen (Johnson & Johnson) COVID-19 vaccine to investigate six reported U.S. cases of rare and severe blood clots that may be linked to the Janssen COVID-19 vaccine. A total of 6.8 million doses of the Janssen (Johnson & Johnson) COVID-19 vaccine have been given in the U.S. Learn more here.

If you have developed a severe headache, abdominal pain, leg pain or shortness of breath up to three weeks after receiving the Janssen (Johnson & Johnson) COVID-19 vaccine, you should seek care immediately. ​

We are communicating to those patients who received the Janssen (Johnson & Johnson) vaccine either at our facilities or at walk-in clinics to make sure their questions are answered. However the Janssen (Johnson & Johnson) vaccine makes up just 3.7 percent of the total vaccinations we've given.


 Media Relations

John Gardner
Marshfield Clinic Health System Director of Communications
715 221-8659

Jeff Starck
Senior Media Relations Specialist - Marshfield, Eau Claire, Ladysmith, Minocqua, Neillsville, Park Falls, & Rice Lake
715 389-4978

Dan Baulch
Senior Communications
Specialist -
Beaver Dam
920 887-4152

Jim Korth
Communications Specialist – Wausau/Weston

Joe Rizzo
Director of Public Relations and Business Development –
Marshfield Medical